Hillsdale Investment Management Inc. Glaukos Corp Transaction History
Hillsdale Investment Management Inc.
- $1.77 Billion
- Q1 2025
A detailed history of Hillsdale Investment Management Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 40 shares of GKOS stock, worth $3,178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$3,178% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding GKOS
# of Institutions
330Shares Held
54.3MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$639 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$486 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$258 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$166 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$159 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $3.78B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...